These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

154 related items for PubMed ID: 2399526

  • 1.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 2.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 3.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 4. Dihydropyridine agonist Bay K 8644 inhibits platelet activation by competitive antagonism of thromboxane A2-prostaglandin H2 receptor.
    Johnson GJ, Dunlop PC, Leis LA, From AH.
    Circ Res; 1988 Mar; 62(3):494-505. PubMed ID: 2449295
    [Abstract] [Full Text] [Related]

  • 5. Influence of verapamil and diltiazem on aggregatory responses in cat and rabbit platelet rich plasma.
    Lippton HL, Horwitz PM, McNamara DB, Landry AZ, Kadowitz PJ.
    Prostaglandins Leukot Med; 1984 Oct; 16(1):121-30. PubMed ID: 6440150
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 8. Effects of prostaglandins, cAMP, and changes in cytosolic calcium on platelet aggregation induced by a thromboxane A2 mimic (U46619).
    Yun JC, Ohman KP, Gill JR, Keiser H.
    Can J Physiol Pharmacol; 1991 May; 69(5):599-604. PubMed ID: 1650650
    [Abstract] [Full Text] [Related]

  • 9.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 10. Antagonism of U46619-induced aggregation of human and canine platelets by four TXA2 receptor antagonists.
    Bush LR, Smith SG.
    Thromb Res; 1986 Nov 01; 44(3):377-89. PubMed ID: 2948294
    [Abstract] [Full Text] [Related]

  • 11.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 12. Dual effects of nimesulide, a COX-2 inhibitor, in human platelets.
    Saeed SA, Afzal MN, Shah BH.
    Life Sci; 1998 Nov 01; 63(20):1835-41. PubMed ID: 9820127
    [Abstract] [Full Text] [Related]

  • 13. Inhibitory effects of endothelial cells and calcium channel blockers on platelet aggregation.
    Yamada Y, Furui H, Furumichi T, Suzuki T, Yamauchi K, Yokota M, Hayashi H, Saito H.
    Jpn Heart J; 1990 Mar 01; 31(2):201-15. PubMed ID: 2113109
    [Abstract] [Full Text] [Related]

  • 14.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 15. Calcium channel blocker treatment of tumor cells induces alterations in the cytoskeleton, mobility of the integrin alpha IIb beta 3 and tumor-cell-induced platelet aggregation.
    Timar J, Chopra H, Rong X, Hatfield JS, Fligiel SE, Onoda JM, Taylor JD, Honn KV.
    J Cancer Res Clin Oncol; 1992 Mar 01; 118(6):425-34. PubMed ID: 1377695
    [Abstract] [Full Text] [Related]

  • 16. Characterization of the inhibition of U46619-mediated human platelet activation by the trimetoquinol isomers. Evidence for endoperoxide/thromboxane A2 receptor blockade.
    Ahn CH, Romstedt KJ, Wallace LJ, Miller DD, Feller DR.
    Biochem Pharmacol; 1988 Aug 01; 37(15):3023-33. PubMed ID: 3134894
    [Abstract] [Full Text] [Related]

  • 17.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 18. Comparison of verapamil and nifedipine in thrombosis models.
    Myers AK, Forman G, Torres Duarte AP, Penhos J, Ramwell P.
    Proc Soc Exp Biol Med; 1986 Oct 01; 183(1):86-91. PubMed ID: 3092231
    [Abstract] [Full Text] [Related]

  • 19.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 20. Inhibition of rabbit platelet phosphodiesterase activity and aggregation by calcium channel blockers.
    Moore JB, Fuller BL, Falotico R, Tolman EL.
    Thromb Res; 1985 Nov 01; 40(3):401-11. PubMed ID: 2417362
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 8.